CVE-2026-29608OpenClaw 2026.3.1 contains an approval integrity vulnerability in system.run node-host execution where argv rewriting changes command semantics.
Updated under an hour ago ()
Does this affect you?
It affects openclaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw 2026.3.1 contains an approval integrity vulnerability in system.run node-host execution where argv rewriting changes command semantics. Attackers can place malicious local scripts in the working directory to execute unintended code despite operator approval of different command text.
- CVSS
- 6.7 MEDIUM (v3.1, NVD)CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-88
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
openclaw openclaw openclaw:openclaw | 2026.3.1 | NVD |
References
- https://github.com/openclaw/openclaw/commit/dded569626b0d8e7bdab10b5e7528b6caf73a0f1patch
- https://github.com/openclaw/openclaw/security/advisories/GHSA-h3rm-6x7g-882fvendor-advisory
- https://www.vulncheck.com/advisories/openclaw-approval-integrity-bypass-via-system-run-argv-rewritingthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.